Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong
· Delayed Price · Currency is HKD 4.290
0.00 (0.00%)
At close: Mar 10, 2026
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 2.65 billion as of March 10, 2026. Its market cap has decreased by -39.38% in one year.
Market Cap
2.65B
Enterprise Value
3.45B
Revenue
31.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.29
Market Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 2.65B, a decrease of -78.13%. That is a compound annual growth rate of -31.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 2.65B | 7.25% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Antengene Corporation | 2.66B |
| SinoMab BioScience | 2.70B |
| Clover Biopharmaceuticals | 2.51B |
| BioDlink International Company | 3.11B |
| Frontage Holdings | 2.23B |
| Medtide | 3.20B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.98B |
| AIM Vaccine | 3.61B |